Heart rate variability is reduced in acromegaly patients and improved by treatment with somatostatin analogues-Reference-Cited by-同舟云学术

Heart rate variability is reduced in acromegaly patients and improved by treatment with somatostatin analogues

Published:2014-09-27 Issue:4 Volume:18 Page:525-534
ISSN:1386-341X
Container-title:Pituitary
language:en
Short-container-title:Pituitary

Author:

Comunello A.,Dassie F.,Martini C.,De Carlo E.,Mioni R.,Battocchio M.,Paoletta A.,Fallo F.,Vettor R.,Maffei P.

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://link.springer.com/content/pdf/10.1007/s11102-014-0605-6.pdf

Reference59 articles.

1. Giustina A, Casanueva F, Cavagnini F, Melmed S (2003) Diagnosis and treatment of acromegaly complications. J Endocrinol Invest 26:1242–1247

2. Lopez-Velasco R, Escobar-Morreale HF, Vega B et al (1997) Cardiac involvement in acromegaly: specific myocardiopathy or consequence of systemic hypertension? J Clin Endocrinol Metab 82:1047–1053

3. Lie JT (1980) Pathology of the heart in acromegaly: anatomic findings in 27 autopsied patients. Am Heart J 100:41–52

4. Melmed S (2001) Acromegaly and cancer: not a problem? J Clin Endocrinol Metab 86:2929–2934

5. Holdaway IMRR, Gamble GD (2004) Factors influencing mortality in acromegaly. J Clin Endocrinol Metab 89:667–674

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Heart’s Function as a Pump Assessed via Impedance Cardiography and the Autonomic System Balance in Patients with Early-Stage Acromegaly;Journal of Clinical Medicine;2024-01-11

2. Acromegalic Cardiomyopathy: An Entity on its own? The Effects of GH and IGF-I Excess and Treatment on Cardiovascular Risk Factors;Archives of Medical Research;2023-12

3. Increased risk of arrhythmias in active acromegaly with complications and persistent uncontrolled active acromegaly;2022-12-08

4. A New Device for Remote Monitoring of Vital Parameters in Acromegalic Patients: Pilot Study;Endocrine, Metabolic & Immune Disorders - Drug Targets;2022-12

5. Complicaciones cardiovasculares asociadas a la acromegalia. Estado del arte;Archivos de Cardiología de México;2022-11-24